Biodesix, Inc. a leader in lung cancer diagnostics, is extending its blood-based testing portfolio with the release of the Nodify CDTTM test, designed to help physicians identify patients
The post Biodesix strengthens lung nodule testing with Nodify CDT Test appeared first on NS Medical Devices.
Original Article: Biodesix strengthens lung nodule testing with Nodify CDT Test